Menu
GeneBe

14-20354109-G-C

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001042618.2(PARP2):c.625G>C(p.Glu209Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000806 in 1,613,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00015 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000073 ( 0 hom. )

Consequence

PARP2
NM_001042618.2 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.300
Variant links:
Genes affected
PARP2 (HGNC:272): (poly(ADP-ribose) polymerase 2) This gene encodes poly(ADP-ribosyl)transferase-like 2 protein, which contains a catalytic domain and is capable of catalyzing a poly(ADP-ribosyl)ation reaction. This protein has a catalytic domain which is homologous to that of poly (ADP-ribosyl) transferase, but lacks an N-terminal DNA binding domain which activates the C-terminal catalytic domain of poly (ADP-ribosyl) transferase. The basic residues within the N-terminal region of this protein may bear potential DNA-binding properties, and may be involved in the nuclear and/or nucleolar targeting of the protein. Two alternatively spliced transcript variants encoding distinct isoforms have been found. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0034641623).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PARP2NM_001042618.2 linkuse as main transcriptc.625G>C p.Glu209Gln missense_variant 8/16 ENST00000429687.8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PARP2ENST00000429687.8 linkuse as main transcriptc.625G>C p.Glu209Gln missense_variant 8/161 NM_001042618.2 P2Q9UGN5-2

Frequencies

GnomAD3 genomes
AF:
0.000151
AC:
23
AN:
152162
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00289
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000269
AC:
67
AN:
249278
Hom.:
0
AF XY:
0.000251
AC XY:
34
AN XY:
135234
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000581
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00295
Gnomad SAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000353
Gnomad OTH exome
AF:
0.000165
GnomAD4 exome
AF:
0.0000732
AC:
107
AN:
1460828
Hom.:
0
Cov.:
29
AF XY:
0.0000702
AC XY:
51
AN XY:
726770
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000448
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00187
Gnomad4 SAS exome
AF:
0.000197
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000810
Gnomad4 OTH exome
AF:
0.0000828
GnomAD4 genome
AF:
0.000151
AC:
23
AN:
152280
Hom.:
0
Cov.:
33
AF XY:
0.000201
AC XY:
15
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00289
Gnomad4 SAS
AF:
0.000622
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.000473
Bravo
AF:
0.000151
ExAC
AF:
0.000199
AC:
24
Asia WGS
AF:
0.000578
AC:
2
AN:
3476
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsFeb 16, 2023The c.664G>C (p.E222Q) alteration is located in exon 8 (coding exon 8) of the PARP2 gene. This alteration results from a G to C substitution at nucleotide position 664, causing the glutamic acid (E) at amino acid position 222 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.70
Cadd
Benign
16
Dann
Benign
0.88
Eigen
Benign
-0.55
Eigen_PC
Benign
-0.55
FATHMM_MKL
Benign
0.46
N
LIST_S2
Benign
0.59
T;T;T
M_CAP
Benign
0.0015
T
MetaRNN
Benign
0.0035
T;T;T
MetaSVM
Benign
-0.92
T
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.32
T
PROVEAN
Benign
-0.96
N;N;N
REVEL
Benign
0.098
Sift
Benign
0.15
T;T;T
Sift4G
Benign
0.41
T;T;T
Polyphen
0.35
B;B;.
Vest4
0.079
MutPred
0.19
.;Loss of solvent accessibility (P = 0.0174);Loss of solvent accessibility (P = 0.0174);
MVP
0.43
MPC
0.10
ClinPred
0.012
T
GERP RS
0.45
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.072
gMVP
0.23

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs562109017; hg19: chr14-20822268; COSMIC: COSV51638160; COSMIC: COSV51638160; API